s

2005 Dec.26 Comprehensive Bio-related Business Tie-up between livedoor Group and TRANS GENIC INC. Joint Investment for Bio Funds Nov.14 Conclusion of Management Agreement with livedoor Securities Co., Ltd. Nov.07 Agreement Concluded on business tie-up between JSW-Research and TRANS GENIC Oct.28 Mouse Strain List updated with 40 more additional mice strains. Oct.24 Agreement concluded on Business Tie-up between Protosera and TRANS GENIC Oct.03 Agreement Concluded on R & D Support Service-related Business Tie-up between Hitachi and TRANS GENIC Sep.29 Agreement Concluded with Mitsubishi Kagaku Institute of Life Sciences to License Right to Use Gene Knockout Mice Sep.22 Obtaining Patents on Knockout Mouse Aug.26 Recognition of Research as Support Project for Establishment of Business-Academia Collaborative New Industries Aug.25 Release of DNA Microarray Kit for Assessment of Chemical Agent Aug.16 Changing the Status of a Main Shareholder July 6 Operation of Kobe Laboratory June 27 Patent Application for New Target for Drug Screening May 30 Conclusion of Feasibility Study Agreement with Vital Star May 16 Notice of Simplified Merger with EU GENE LTD. Apr.28 Introducing new products;"The Manual for Reproductive Engineering Techniques in Mice" (CD-ROM) Apr.27 Mouse Strain List updated with 18 more additional mice strains. Apr.26 Publication of Study Producing High-Affinity Antibody Using Ganp Gene-Transgenic Mouse Apr.26 Notice of Conclusion of Basic Agency Agreement with Charles River Laboratories Japan, Inc. regarding Distribution of Knockout Mice Apr.18 Highly Sensitive Immunological Assay System for Cancer Diagnosis Using Urine Samples: The Development of In Vitro Diagnostic Products Feb.15 Completion and Renewed Conclusion of the z`greement on the Exclusive Provision of Information about Gene Knockout Micezõith Sumitomo Pharmaceuticals Co., Ltd. Feb.08 Openig of Kobe Office Jun.24 Patent Application for Assay System for Cancer Diagnosis Using Urine Samples >>2010 >>2009 >>2008 >>2007 >>2006 >>2005 >>2004